selegiline has been researched along with Aging in 108 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (15.74) | 18.7374 |
1990's | 57 (52.78) | 18.2507 |
2000's | 24 (22.22) | 29.6817 |
2010's | 8 (7.41) | 24.3611 |
2020's | 2 (1.85) | 2.80 |
Authors | Studies |
---|---|
Ferdinandy, P; Fürst, S; Gyires, K; Miklya, I; Muraoka, S; Yoneda, F | 1 |
Farkas, J; Gáborján, A; Humli, V; Köles, L; Miklya, I; Polony, G; Szepesy, J; Szirmai, Á; Tábi, T; Tamás, L; Tímár, J; Vizi, ES; Zelles, T | 1 |
Miklya, I | 3 |
Knoll, J; Miklya, I | 1 |
Malavolta, M; Mocchegiani, E | 1 |
Cohen, S; Dror, V; Eliash, S; Rehavi, M | 1 |
Bagriyanik, HA; Ergur, BU; Kiray, M; Pekcetin, C; Topcu, A | 1 |
Campbell, S; Kozan, B; Trettien, A | 1 |
Henn, FA; Mirrione, MM; Schulz, D | 1 |
James, TJ; Subramanian, MV | 2 |
Mishra, M; Sharma, D; Singh, R; Singh, S | 1 |
Bellinger, DL; Boehm, GW; Felten, DL; Madden, KS; Stevens, SY; Thyagarajan, S | 1 |
Kaur, J; Sharma, D; Singh, R; Singh, S | 1 |
Hatakeyama, Y; Nakano, N; Yoshida, T | 1 |
Currer, JM; Flurkey, K | 1 |
Landsberg, G | 1 |
Bagriyanik, HA; Buldan, Z; Ergur, BU; Kiray, M; Ozyurt, D; Pekcetin, C; Uysal, N | 1 |
Bromberg, E; Caldana, F; de Lima, MN; Laranja, DC; Roesler, R; Schröder, N | 1 |
Kitani, K | 1 |
Alper, G; Caglayan, O; Duman, E; Irer, S; Yilmaz, C | 1 |
Ames, D; Ritchie, C | 1 |
Alper, GE; Duman, E; Irer, SV; Saatcioglu, F; Sezer, ED; Yilmaz, C | 1 |
Aksu, I; Bagriyanik, A; Buldan, Z; Ergur, BU; Kiray, M; Pekcetin, C | 1 |
Chen, JJ; Fernandez, HH | 1 |
Fung, SC; Kong, YC; Lam, DM | 1 |
Jellinger, K; Riederer, P | 1 |
Benedetti, MS; Fowler, CJ | 1 |
Dallo, J; Knoll, J; Yen, TT | 2 |
Knoll, J | 12 |
Fowler, CJ; Marcusson, J; Oreland, L; Winblad, B | 1 |
Lai, JC; Leung, TK; Lim, L | 1 |
Lillrank, S; Oja, SS; Saransaari, P; Suhonen, J | 1 |
Amenta, F; Bongrani, S; Bronzetti, E; Cadel, S; Ricci, A; Valsecchi, B; Zeng, YC | 2 |
Gupta, M; Wiener, HL | 1 |
Delanney, LE; Finnegan, KT; Irwin, I; Langston, JW | 1 |
Amenta, F; Bongrani, S; Cadel, S; Ferrante, F; Valsecchi, B; Zeng, YC | 1 |
Berry, MD; Juorio, AV; Paterson, IA | 1 |
Meites, J; Quadri, SK; Thyagarajan, S | 1 |
Correa, RM; Oxenkrug, GF; Requintina, PJ; Yuwiler, A | 1 |
Hafner, U; Müller, WE; Pohl, O; Stoll, S | 1 |
Amenta, F; Bongrani, S; Cadel, S; Ricci, A; Valsecchi, B; Zeng, YC | 1 |
Head, E; Ivy, GO; Milgram, NW; Murphy, MP; Reid, C; Rick, JT | 1 |
Antognini, A; Basso, A; Piantanelli, L; Rossolini, G; Testa, R; Viticchi, C; Zaia, A | 1 |
Amenta, F; Bograni, S; Cadel, S; Ferrante, F; Valsecchi, B; Vega, JA | 1 |
Heinonen, E; Riekkinen, P; Sirviö, J; Yavich, L | 1 |
Carrillo, MC; Ivy, GO; Kanai, S; Kitani, K; Miyasaka, K; Sato, Y | 3 |
Clow, A; Glover, V; Sandler, M | 1 |
Barber, AJ; Boulton, AA; Yu, PH | 1 |
Ansari, KS; Kruck, TP; Tatton, WG; Yu, PH | 1 |
Singer, TP; Tipton, KF | 1 |
Carrillo, MC; Ivy, GO; Kanai, S; Kitani, K; Nokubo, M; Sato, Y | 1 |
Ali, SF; Freyaldenhoven, TE; Hart, RW | 1 |
Bruyette, DS; Cotman, CW; Cummings, BJ; DePaoli, A; Head, E; Milgram, NW; Ruehl, WW | 1 |
Ivy, GO; Milgram, NW; Murphy, MP; Rick, JT | 1 |
Nagy, IZ | 1 |
Cano, J; de la Cruz, CP; Machado, A; Revilla, E; Rodríguez-Gómez, JA; Steffen, V | 1 |
Haapalinna, A; Heinonen, E; Hervonen, A; Salonen, T; Suhonen, J | 1 |
Hartley, J; Head, E; Ivy, GO; Kameka, AM; Mehta, R; Milgram, NW; Ruehl, WW | 1 |
Haapalinna, A; Heinonen, E; Koivisto, E; Puumala, T; Riekkinen, PJ; Sirviö, J; Yavich, L | 1 |
Amenta, F; Barili, P; Battisti, A; Ferrante, F; Valsecchi, B | 1 |
Archer, JR; Harrison, DE | 1 |
Bruyette, DS; Darling, L; Entriken, T; Griffin, D; Ruehl, WW | 1 |
Cano, J; Machado, A; Rodríguez-Gómez, JA; Romero-Ramos, M; Venero, JL | 1 |
Cano, J; De la Cruz, CP; Machado, A; Revilla, E; Rodríguez-Gómez, JA; Vizuete, ML | 1 |
Mahmood, I | 1 |
Fowler, JS; Logan, J; MacGregor, RR; Pappas, N; Shea, C; Volkow, ND; Wang, GJ | 1 |
Bruyette, DS; Cummings, BJ; Hart, B; Head, E; Neilson, J; Ruehl, WW | 1 |
Felten, DL; Felten, SY; ThyagaRajan, S | 1 |
Felten, DL; Madden, KS; Thyagarajan, S | 1 |
Dimitrova, SS; Felten, DL; Felten, SY; Kalvass, JC; Madden, KS; ThyagaRajan, S | 1 |
Berry, MD; Boulton, AA; Gillott, C; Jordens, RG | 1 |
Ersoz, B; Girgin, FK; Mentes, G; Ozgonul, M; Sozmen, EY | 1 |
Maruyama, W; Naoi, M | 1 |
Carrillo, MC; Ivy, GO; Kanai, S; Kitani, K | 1 |
Felten, DL; Madden, KS; Stevens, SY; ThyagaRajan, S | 1 |
Carrillo, MC; Ivy, GO; Kanai, S; Kitani, K; Maruyama, W; Minami, C; Yamamoto, T | 1 |
Carrillo, MC; Ivy, GO; Kanai, S; Kitani, K; Minami, C; Yamamoto, T | 1 |
Felten, DL; ThyagaRajan, S | 1 |
Carrillo, MC; Isobe, K; Ivy, GO; Kanai, S; Kitani, K; Maehara, K; Minami, C | 1 |
Callingham, BA; Lyles, GA | 1 |
Head, E; Milgram, NW | 1 |
Knoll, J; Kummert, M; Sugár, J; Tóth, V | 1 |
Wagner, GC; Walsh, SL | 1 |
Aquilonius, SM; d'Argy, R; Gillberg, PG; Halldin, C; Jossan, SS; Långström, B; Oreland, L | 1 |
Dluzen, DE; McDermott, JL | 1 |
Borelli, G; Brandeis, R; Cadel, S; Kapon, Y; Sapir, M; Valsecchi, B | 1 |
Ivy, GO; Mendonca, A; Milgram, NW; Nellis, P; Racine, RJ | 1 |
Cohen, RM; Mellow, AM; Mueller, EA; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN | 1 |
Amenta, F; Bonifati, V; Collier, WL; Meco, M; Ramacci, MT | 1 |
Harik, SI; Kalaria, RN | 1 |
29 review(s) available for selegiline and Aging
Article | Year |
---|---|
The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).
Topics: Aging; Alzheimer Disease; Animals; Brain; Catecholamines; Depressive Disorder, Major; Dopamine; History, 20th Century; Humans; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Rats; Selegiline | 2016 |
Possible new antiaging strategies related to neuroendocrine-immune interactions.
Topics: Adult; Aged; Aging; Animals; Anticarcinogenic Agents; Antioxidants; Carnosine; Child, Preschool; Dogs; Female; Ghrelin; Humans; Leptin; Longevity; Male; Neuroimmunomodulation; Nitric Oxide Donors; Selegiline; Young Adult; Zinc | 2008 |
[Slowing the age-induced decline of brain function with prophylactic use of (-)-deprenyl (Selegiline, Jumex). Current international view and conclusions 25 years after the Knoll's proposal].
Topics: Aging; Apoptosis; Brain; Cell Culture Techniques; Humans; Mental Disorders; Neurodegenerative Diseases; Neuroprotective Agents; Selegiline | 2009 |
[Mild cognitive impairment].
Topics: Aging; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Diagnosis, Differential; Disease Progression; Humans; Psychiatric Status Rating Scales; Selegiline; Severity of Illness Index; Vitamin E | 2003 |
Pitfalls of animal model systems in ageing research.
Topics: Aging; Animals; Biomarkers; Dehydroepiandrosterone; Humans; Models, Animal; Research; Resveratrol; Selegiline; Stilbenes | 2004 |
Therapeutic agents for the treatment of cognitive dysfunction syndrome in senior dogs.
Topics: Aging; Animals; Behavior, Animal; Cognition Disorders; Complementary Therapies; Diet Therapy; Dogs; Environment; Humans; Neuroprotective Agents; Neuropsychological Tests; Selegiline | 2005 |
Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
Topics: Aged; Aging; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Homes for the Aged; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Nursing Homes; Parkinson Disease; Selegiline | 2007 |
Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes.
Topics: Aging; Alzheimer Disease; Animals; Antiparkinson Agents; Drug Administration Schedule; Humans; Parkinson Disease; Selegiline; Substantia Nigra | 1995 |
Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders.
Topics: Aging; Alzheimer Disease; Animals; Cognition Disorders; Depressive Disorder; Humans; Longevity; Mental Disorders; Monoamine Oxidase Inhibitors; Nervous System Diseases; Parkinson Disease; Schizophrenia; Selegiline | 1994 |
Age-related memory decline and longevity under treatment with selegiline.
Topics: Aging; Animals; Avoidance Learning; Cricetinae; Female; Longevity; Maze Learning; Memory Disorders; Mesocricetus; Mice; Mice, Inbred Strains; Selegiline | 1994 |
Effects of L-deprenyl on manifestations of aging in the rat and dog.
Topics: Aging; Animals; Body Weight; Dogs; Female; Learning; Life Expectancy; Male; Memory; Rats; Rats, Inbred F344; Selegiline | 1994 |
Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
Topics: Aging; Animals; Corpus Striatum; Enzyme Induction; Free Radicals; Humans; Isatin; Life Expectancy; Nerve Degeneration; Parkinson Disease; Pergolide; Rats; Selegiline; Substantia Nigra; Superoxide Dismutase | 1993 |
The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases.
Topics: Aging; Alzheimer Disease; Animals; Avoidance Learning; Catalase; Corpus Striatum; Drug Therapy, Combination; Learning; Levodopa; Male; Neurons; Parkinson Disease; Rats; Selegiline; Substantia Nigra; Superoxide Dismutase | 1993 |
Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Aging; Animals; Biological Transport; Humans; Mitochondria; Nervous System; Oxidation-Reduction; Parkinson Disease; Selegiline; Species Specificity | 1993 |
Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy.
Topics: Aging; Alzheimer Disease; Animals; Cognition Disorders; Dementia; Disease Models, Animal; Dogs; Humans; Selegiline | 1995 |
On the possible role of nootropica in geriatric prevention and therapy.
Topics: Aging; Free Radical Scavengers; Humans; Nootropic Agents; Piracetam; Proline; Selegiline | 1996 |
Management of canine pituitary-dependent hyperadrenocorticism with l-deprenyl (Anipryl).
Topics: Adrenal Cortex Diseases; Adrenocortical Hyperfunction; Aging; Animals; Dog Diseases; Dogs; Dopamine; Dose-Response Relationship, Drug; Monoamine Oxidase Inhibitors; Pituitary Gland; Selegiline | 1997 |
Clinical pharmacokinetics and pharmacodynamics of selegiline. An update.
Topics: Administration, Cutaneous; Aging; Area Under Curve; Cohort Studies; Drug Interactions; Female; Food-Drug Interactions; Humans; Intestinal Absorption; Male; Monoamine Oxidase Inhibitors; Selegiline; Sex Factors; Structure-Activity Relationship; Tissue Distribution | 1997 |
Alterations in sympathetic noradrenergic innervation in lymphoid organs with age.
Topics: Aging; Animals; Humans; Lymphatic System; Monoamine Oxidase Inhibitors; Norepinephrine; Selegiline; Spleen; Sympathetic Nervous System; Thymus Gland | 1998 |
(-)Deprenyl (Selegiline): past, present and future.
Topics: Aging; Alzheimer Disease; Animals; Brain Chemistry; Humans; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline | 2000 |
Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain.
Topics: Aging; Alzheimer Disease; Animals; Benzofurans; Brain; Catecholamines; Depression; Humans; Neuroprotective Agents; Parkinson Disease; Propylamines; Selegiline; Serotonin | 2001 |
Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
Topics: Aging; Alkynes; Animals; Antioxidants; Brain; Brain Chemistry; Catalase; Corpus Striatum; Cricetinae; Dogs; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Induction; Female; Free Radicals; Heart; Humans; Indans; Kidney; Longevity; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neuroprotective Agents; Organ Specificity; Rats; Rats, Inbred F344; Selegiline; Superoxide Dismutase | 2001 |
Pharmacological interventions in aging and age-associated disorders: potentials of propargylamines for human use.
Topics: Aging; Animals; Catalase; Free Radical Scavengers; Humans; Life Expectancy; Neuroprotective Agents; Pargyline; Propylamines; Selegiline; Superoxide Dismutase | 2002 |
Modulation of neuroendocrine--immune signaling by L-deprenyl and L-desmethyldeprenyl in aging and mammary cancer.
Topics: Aging; Amphetamines; Animals; Cardiovascular System; Humans; Immune System; Lymphoid Tissue; Mammary Neoplasms, Animal; Neuroimmunomodulation; Neuroprotective Agents; Neurosecretory Systems; Selegiline; Signal Transduction | 2002 |
Why (--)deprenyl prolongs survivals of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects.
Topics: Aging; Animals; Antioxidants; Brain; Brain-Derived Neurotrophic Factor; Catalase; Cytokines; Dose-Response Relationship, Drug; Monoamine Oxidase Inhibitors; Nerve Growth Factors; Neuroprotective Agents; Selegiline; Superoxide Dismutase | 2002 |
Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases.
Topics: Aging; Animals; Drug Administration Schedule; Humans; Nervous System Diseases; Selegiline; Structure-Activity Relationship | 1992 |
(-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic system.
Topics: Aging; Alzheimer Disease; Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Parkinson Disease; Rats; Receptors, Dopamine; Selegiline; Substantia Nigra | 1992 |
R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
Topics: Aging; Animals; Biogenic Amines; Brain; Catecholamines; Corpus Striatum; Dopamine; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Phenethylamines; Receptors, Cell Surface; Receptors, Dopamine; Selegiline; Substantia Nigra; Synapses | 1987 |
The facilitation of dopaminergic activity in the aged brain by (-)deprenyl. A proposal for a strategy to improve the quality of life in senescence.
Topics: Aged; Aging; Animals; Brain; Depression; Dopamine; Geriatrics; Humans; Male; Monoamine Oxidase Inhibitors; Parkinson Disease; Phenethylamines; Quality of Life; Rats; Selegiline; Sexual Behavior | 1985 |
1 trial(s) available for selegiline and Aging
Article | Year |
---|---|
A noncomparative open-label study evaluating the effect of selegiline hydrochloride in a clinical setting.
Topics: Aging; Animals; Cognition Disorders; Dog Diseases; Dogs; Female; Male; Neuroprotective Agents; Selegiline | 2001 |
78 other study(ies) available for selegiline and Aging
Article | Year |
---|---|
Geroprotection in the future. In memoriam of Joseph Knoll: The selegiline story continues.
Topics: Aging; Brain; Drug Development; Geriatrics; History, 20th Century; Humans; Life Expectancy; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Selegiline | 2020 |
Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice.
Topics: Administration, Oral; Aging; Animals; Antiparkinson Agents; Auditory Threshold; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Hearing Loss, Sensorineural; Humans; Male; Mice, Inbred BALB C; Mice, Inbred DBA; Protective Agents; Selegiline; Synaptic Transmission | 2021 |
[Primary prevention with enhancer substances for a longer and healthier life].
Topics: Aging; Antiparkinson Agents; Chronic Disease; Disease Progression; Education, Medical; Feeding Behavior; Humans; Hungary; Life Expectancy; Life Style; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Primary Prevention; Secondary Prevention; Selegiline; Tertiary Prevention | 2013 |
Longevity study with low doses of selegiline/(-)-deprenyl and (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine (BPAP).
Topics: Aging; Animals; Learning; Longevity; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Rats, Wistar; Selegiline | 2016 |
Neuroprotection by rasagiline in thiamine deficient rats.
Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Brain; Disease Models, Animal; Indans; Kaplan-Meier Estimate; Male; Maze Learning; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nerve Degeneration; Neuroprotective Agents; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Selegiline; Thiamine Deficiency | 2009 |
Antioxidant and antiapoptotic activities of deprenyl and estradiol co-administration in aged rat kidney.
Topics: Aging; Animals; Apoptosis; Drug Therapy, Combination; Estradiol; Estrogens; Female; Kidney; Lipid Peroxidation; Monoamine Oxidase Inhibitors; Oxidative Stress; Rats; Rats, Wistar; Selegiline | 2009 |
Cognitive aspects of congenital learned helplessness and its reversal by the monoamine oxidase (MAO)-B inhibitor deprenyl.
Topics: Aging; Animals; Anxiety; Cognition; Electroshock; Exploratory Behavior; Habituation, Psychophysiologic; Helplessness, Learned; Male; Monoamine Oxidase Inhibitors; Motor Activity; Neuropsychological Tests; Rats; Rats, Inbred Strains; Selegiline; Species Specificity; Time Factors | 2010 |
Supplementation of deprenyl attenuates age associated alterations in rat cerebellum.
Topics: Aging; Animals; Cerebellum; Dietary Supplements; Hexosamines; Hexoses; Male; Organ Size; Purkinje Cells; Rats; Rats, Wistar; Selegiline | 2010 |
Age-related protective effect of deprenyl on changes in the levels of diagnostic marker enzymes and antioxidant defense enzymes activities in cerebellar tissue in Wistar rats.
Topics: Aging; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Catalase; Cerebellum; Creatine Kinase; Glutathione Peroxidase; Glutathione Transferase; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Rats; Rats, Wistar; Selegiline; Superoxide Dismutase | 2010 |
Effect of L-deprenyl treatment on electrical activity, Na+, K+ ATPase, and protein kinase C activities in hippocampal subfields (CA1 and CA3) of aged rat brain.
Topics: Action Potentials; Aging; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Electroencephalography; Electrophysiological Phenomena; Learning; Male; Protein Kinase C; Rats; Rats, Wistar; Reaction Time; Regression Analysis; Selegiline; Sodium-Potassium-Exchanging ATPase | 2012 |
L-Deprenyl reverses age-associated decline in splenic norepinephrine, interleukin-2 and interferon-γ production in old female F344 rats.
Topics: Aging; Animals; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Female; Immunity, Cellular; Interferon-gamma; Interleukin-2; Neuroprotective Agents; Norepinephrine; Rats; Rats, Inbred F344; Selegiline; Spleen; Sympathetic Nervous System | 2013 |
Neurostimulatory and antioxidative effects of L-deprenyl in aged rat brain regions.
Topics: Action Potentials; Aging; Animals; Antioxidants; Brain; Electrophysiology; Glutathione Peroxidase; Glutathione Transferase; Lipid Peroxidation; Lipofuscin; Male; Neuroprotective Agents; Rats; Rats, Wistar; Selegiline; Sodium-Potassium-Exchanging ATPase | 2003 |
Deprenyl and the relationship between its effects on spatial memory, oxidant stress and hippocampal neurons in aged male rats.
Topics: Aging; Animals; Glutathione Peroxidase; Hippocampus; Lipid Peroxidation; Male; Memory; Monoamine Oxidase Inhibitors; Neostriatum; Neurons; Oxidative Stress; Prefrontal Cortex; Rats; Rats, Wistar; Selegiline; Spatial Behavior; Superoxide Dismutase | 2006 |
Reversal of age-related deficits in object recognition memory in rats with l-deprenyl.
Topics: Aging; Animals; Antiparkinson Agents; Behavior, Animal; Injections; Male; Memory; Memory Disorders; Memory, Short-Term; Rats; Rats, Wistar; Recognition, Psychology; Selegiline | 2005 |
"My involvement in aging research was just a series of coincidences" An interview with Kenichi Kitani. Interview by Sataro Goto.
Topics: Aging; Brain; Caloric Restriction; Geriatrics; Life Style; Liver; Longevity; Reactive Oxygen Species; Selegiline | 2005 |
Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aging; Animals; Antioxidants; Blood Glucose; Body Weight; Deoxyguanosine; Diabetes Mellitus, Experimental; Disease Models, Animal; DNA Damage; Gliclazide; Hypoglycemic Agents; Lipid Peroxidation; Liver; Male; Malondialdehyde; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidants; Oxidative Stress; Rats; Rats, Inbred Strains; Selegiline; Superoxide Dismutase; Vitamin A; Vitamin E | 2005 |
Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
Topics: Aging; Alzheimer Disease; Antioxidants; Cognition Disorders; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidative Stress; Selegiline; Vitamin E | 2007 |
The effect of l-deprenyl on tissue mRNA expressions of NOS isoforms and NO levels in an experimental diabetes mellitus model.
Topics: Aging; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Heart; Isoenzymes; Liver; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; RNA, Messenger; Selegiline; Treatment Outcome | 2007 |
Suppression of apoptosis and oxidative stress by deprenyl and estradiol in aged rat liver.
Topics: Aging; Animals; Apoptosis; Estradiol; Female; In Situ Nick-End Labeling; Lipid Peroxidation; Liver; Ovariectomy; Oxidative Stress; Rats; Rats, Wistar; Selegiline; Thiobarbituric Acid Reactive Substances | 2007 |
Postnatal development of dopaminergic neurons in the rabbit retina.
Topics: Aging; Animals; Animals, Newborn; Benzylamines; Clorgyline; Dopamine; Kinetics; Monoamine Oxidase; Neurons; Potassium; Rabbits; Retina; Selegiline; Tyrosine 3-Monooxygenase | 1981 |
Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline).
Topics: Aged; Aging; Alzheimer Disease; Brain; Central Nervous System; Female; Humans; Huntington Disease; Male; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phenethylamines; Selegiline | 1983 |
The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
Topics: Aging; Animals; Brain; Clorgyline; Dopamine; Isoenzymes; Kinetics; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Rats, Inbred Strains; Selegiline; Species Specificity | 1983 |
Long-lasting, true aphrodisiac effect of (-)-deprenyl in sexually sluggish old male rats.
Topics: Aging; Amphetamine; Animals; Aphrodisiacs; Castration; Clorgyline; Copulation; Male; Phenethylamines; Rats; Selegiline; Sexual Behavior, Animal; Time Factors | 1983 |
Deprenyl (selegiline): the history of its development and pharmacological action.
Topics: Aging; Animals; Brain; Depression; Dopamine; Drug Evaluation; History, 20th Century; Humans; Male; Monoamine Oxidase Inhibitors; Neurons; Parkinson Disease; Phenethylamines; Rats; Rats, Inbred Strains; Selegiline; Sexual Behavior | 1983 |
Titration of human brain monoamine oxidase -A and -B by clorgyline and L-deprenil.
Topics: Adult; Aged; Aging; Benzylamines; Brain; Cerebral Cortex; Child, Preschool; Clorgyline; Humans; In Vitro Techniques; Kinetics; Male; Middle Aged; Monoamine Oxidase; Nerve Tissue Proteins; Phenethylamines; Propylamines; Selegiline; Serotonin | 1980 |
The regional distribution of monoamine oxidase activities towards different substrates: effects in rat brain of chronic administration of manganese chloride and of ageing.
Topics: Aging; Animals; Benzylamines; Brain; Chlorides; Clorgyline; Dopamine; Female; Male; Manganese; Manganese Compounds; Monoamine Oxidase; Rats; Selegiline; Serotonin; Tissue Distribution | 1981 |
Effects of long-term treatment with a monoamine oxidase B inhibitor, selegeline (L-deprenyl), on amino acid transmitter systems in the ageing rat brain.
Topics: Aging; Animals; Brain Chemistry; Dizocilpine Maleate; Glutamic Acid; In Vitro Techniques; Male; Membranes; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B; Receptors, N-Methyl-D-Aspartate; Selegiline | 1995 |
Influence of long-term treatment with L-deprenyl on the age-dependent changes in rat brain microanatomy.
Topics: Aging; Animals; Body Weight; Cerebellar Cortex; Cognition; Frontal Lobe; Hippocampus; Lipofuscin; Male; Organ Size; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Selegiline; Silver Staining; Staining and Labeling; Time Factors | 1994 |
Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Corpus Striatum; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Neurotransmitter Agents; Olfactory Pathways; Selegiline | 1995 |
Effect of long-term treatment with L-deprenyl on the age-dependent microanatomical changes in the rat hippocampus.
Topics: Aging; Animals; Evaluation Studies as Topic; Hippocampus; Male; Monoamine Oxidase; Rats; Rats, Sprague-Dawley; Selegiline; Time Factors | 1995 |
Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Clorgyline; Corpus Striatum; Dopamine; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Selegiline | 1995 |
Influence of treatment with L-deprenyl on the structure of the cerebellar cortex of aged rats.
Topics: Aging; Animals; Body Weight; Cerebellar Cortex; Male; Neurons; Purkinje Cells; Rats; Rats, Sprague-Dawley; Selegiline | 1994 |
Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats.
Topics: Aging; Animals; Body Weight; Estrus; Female; Mammary Neoplasms, Experimental; Menopause; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Sprague-Dawley; Selegiline | 1995 |
The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N rats.
Topics: Aging; Animals; Female; Indoles; Melatonin; Monoamine Oxidase; Pineal Gland; Rats; Rats, Inbred F344; Reference Values; Selegiline; Time Factors | 1994 |
Neuroanatomy of aging brain. Influence of treatment with L-deprenyl.
Topics: Aging; Animals; Astrocytes; Cell Count; Frontal Lobe; Hippocampus; Histocytochemistry; Male; Monoamine Oxidase; Neurons; Rats; Rats, Sprague-Dawley; Selegiline | 1994 |
Influence of L-deprenyl treatment on mouse survival kinetics.
Topics: Aging; Animals; Crosses, Genetic; Life Expectancy; Mice; Mice, Inbred BALB C; Mice, Nude; Selegiline; Survival Analysis | 1994 |
Microanatomical changes in the frontal cortex of aged rats: effect of L-deprenyl treatment.
Topics: Aging; Animals; Cell Count; Frontal Lobe; Male; Rats; Rats, Sprague-Dawley; Reference Values; Selegiline | 1994 |
The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats.
Topics: Aging; Animals; Learning; Memory; Rats; Rats, Inbred Strains; Scopolamine; Selegiline; Space Perception | 1993 |
(-)deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice.
Topics: Aging; Animals; Brain; Catalase; Cerebral Cortex; Corpus Striatum; Male; Mice; Mice, Inbred C57BL; Random Allocation; Selegiline; Substantia Nigra; Superoxide Dismutase | 1994 |
The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats.
Topics: Aging; Animals; Body Weight; Brain; Catalase; Dose-Response Relationship, Drug; Female; Rats; Rats, Inbred F344; Selegiline; Superoxide Dismutase; Time Factors | 1994 |
Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice.
Topics: Aging; Animals; Behavior, Animal; Body Weight; Brain; Drinking; Isoenzymes; Locomotion; Male; Memory; Mice; Monoamine Oxidase Inhibitors; Pargyline; Selegiline; Time Factors | 1993 |
Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition.
Topics: Aging; Animals; Axons; Brain Stem; Cell Survival; Choline O-Acetyltransferase; Dose-Response Relationship, Drug; Facial Nerve; Functional Laterality; Monoamine Oxidase; Motor Neurons; Rats; Rats, Sprague-Dawley; Selegiline; Stereoisomerism; Time Factors | 1993 |
The optimal dosage of (-)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats.
Topics: Aging; Analysis of Variance; Animals; Brain; Catalase; Dose-Response Relationship, Drug; Female; Isoenzymes; Male; Organ Specificity; Rats; Rats, Inbred F344; Selegiline; Sex Factors; Superoxide Dismutase | 1993 |
MPTP- and MPP(+)-induced effects on body temperature exhibit age- and strain-dependence in mice.
Topics: 1-Methyl-4-phenylpyridinium; Aging; Analysis of Variance; Animals; Body Temperature Regulation; Dopamine Agents; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Selegiline; Species Specificity | 1995 |
Short intertrial intervals impair water maze performance in old Fischer 344 rats.
Topics: Aging; Animals; Disease Susceptibility; Escape Reaction; Fatigue; Female; Male; Maze Learning; Monoamine Oxidase Inhibitors; Psychomotor Performance; Rats; Rats, Inbred F344; Reaction Time; Selegiline; Stress, Physiological; Swimming; Temperature; Time Factors; Water | 1996 |
Protection of the aged substantia nigra of the rat against oxidative damage by (-)-deprenyl.
Topics: Aging; Animals; Dopamine; Male; Monoamine Oxidase Inhibitors; Oxidative Stress; Rats; Rats, Wistar; Selegiline; Substantia Nigra; Tyrosine | 1996 |
Monoamine oxidase B inhibitor selegiline protects young and aged rat peripheral sympathetic neurons against 6-hydroxydopamine-induced neurotoxicity.
Topics: Aging; Animals; Immunohistochemistry; Male; Microscopy, Fluorescence; Monoamine Oxidase Inhibitors; Oxidopamine; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Selegiline; Superior Cervical Ganglion; Tyrosine 3-Monooxygenase | 1996 |
The effects of L-deprenyl on spatial short term memory in young and aged dogs.
Topics: Aging; Animals; Dogs; Female; Male; Memory, Short-Term; Selegiline; Time Factors | 1996 |
Long term treatment with (-)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain.
Topics: Aging; Animals; Brain; Catalase; Male; Mice; Mice, Inbred C57BL; Selegiline; Superoxide Dismutase | 1996 |
The systemic administration of tacrine or selegiline facilitate spatial learning in aged fisher 344 rats.
Topics: Aging; Animals; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Escape Reaction; Male; Maze Learning; Monoamine Oxidase Inhibitors; Rats; Rats, Inbred F344; Reaction Time; Selegiline; Tacrine | 1996 |
Effect of treatment with L-deprenyl on age-dependent microanatomical changes in the rat kidney.
Topics: Aging; Analysis of Variance; Animals; Evaluation Studies as Topic; Image Processing, Computer-Assisted; Kidney; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selegiline | 1996 |
L-deprenyl treatment in aged mice slightly increases life spans, and greatly reduces fecundity by aged males.
Topics: Aging; Animals; Eating; Female; Fertility; Male; Mice; Selegiline; Superoxide Dismutase | 1996 |
Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Blotting, Western; Dopamine; Dopamine Uptake Inhibitors; Free Radicals; Male; Nomifensine; Oxidative Stress; Proteins; Rats; Rats, Wistar; Selegiline; Substantia Nigra; Tyrosine 3-Monooxygenase | 1997 |
(-)-Deprenyl treatment restores serum insulin-like growth factor-I (IGF-I) levels in aged rats to young rat level.
Topics: Age Factors; Aging; Animals; Biomarkers; Insulin-Like Growth Factor I; Male; Neuroprotective Agents; Neurotransmitter Agents; Rats; Rats, Wistar; Selegiline; Tyrosine 3-Monooxygenase | 1997 |
Visualization of monoamine oxidase in human brain.
Topics: Adult; Aged; Aged, 80 and over; Aging; Brain; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Monoamine Oxidase; Organ Specificity; Radionuclide Imaging; Reference Values; Regression Analysis; Selegiline | 1998 |
Therapeutic actions of L-deprenyl in dogs: a model of human brain aging.
Topics: Aging; Animals; Brain; Cognition Disorders; Dementia; Dogs; Humans; Models, Biological; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline | 1998 |
Restoration of sympathetic noradrenergic nerve fibers in the spleen by low doses of L-deprenyl treatment in young sympathectomized and old Fischer 344 rats.
Topics: Adrenergic Fibers; Aging; Animals; Immunity, Cellular; Male; Monoamine Oxidase Inhibitors; Nerve Regeneration; Nerve Tissue Proteins; Neuropeptide Y; Norepinephrine; Oxidopamine; Rats; Rats, Inbred F344; Selegiline; Spleen; Sympathectomy, Chemical; Tyrosine 3-Monooxygenase | 1998 |
L-deprenyl-induced increase in IL-2 and NK cell activity accompanies restoration of noradrenergic nerve fibers in the spleens of old F344 rats.
Topics: Aging; Animals; B-Lymphocytes; Immunoglobulin M; Interleukin-2; Killer Cells, Natural; Lymphocyte Count; Male; Nerve Fibers; Nerve Regeneration; Neuropeptide Y; Neuroprotective Agents; Norepinephrine; Rats; Rats, Inbred F344; Selegiline; Spleen | 1998 |
Prolongation of life in an experimental model of aging in Drosophila melanogaster.
Topics: Aging; Animals; Drosophila melanogaster; Free Radical Scavengers; Galactose; Longevity; Mutation; Reactive Oxygen Species; Selegiline; Sucrose; Superoxide Dismutase | 1999 |
Link between catecholamine and nitric oxide metabolism.
Topics: Aging; Animals; Catecholamines; Monoamine Oxidase; Nitrates; Nitric Oxide; Nitrites; Rats; Selegiline | 1999 |
Neuroprotection by (-)-deprenyl and related compounds.
Topics: Aging; Amphetamines; Animals; Antioxidants; Apoptosis; Cattle; DNA Damage; DNA, Neoplasm; Indans; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Nitrates; Oxidants; Parkinson Disease; Selegiline; Tumor Cells, Cultured | 1999 |
Pharmacological modifications of endogenous antioxidant enzymes with special reference to the effects of deprenyl: a possible antioxidant strategy.
Topics: Aging; Animals; Antioxidants; Catalase; Cats; Cricetinae; Dogs; Female; Glutathione Peroxidase; Glutathione Transferase; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Nitrobenzenes; Oxidoreductases; Rats; Rats, Inbred F344; Selegiline; Superoxide Dismutase; Triterpenes; Up-Regulation; Ursodeoxycholic Acid; Ursolic Acid | 1999 |
Restoration of splenic noradrenergic nerve fibers and immune reactivity in old F344 rats: a comparison between L-deprenyl and L-desmethyldeprenyl.
Topics: Adrenergic Fibers; Aging; Amphetamines; Animals; Male; Nerve Regeneration; Norepinephrine; Rats; Rats, Inbred F344; Selegiline; Spleen | 2000 |
Selective influences of age and thyroid hormones on type A monoamine oxidase of the rat heart.
Topics: Aging; Animals; Clorgyline; Heart; In Vitro Techniques; Monoamine Oxidase; Myocardium; Organ Size; Rats; Selegiline; Substrate Specificity; Thyroid Hormones | 1979 |
Changes in spontaneous behavior in the dog following oral administration of L-deprenyl.
Topics: Aging; Animals; Behavior, Animal; Dogs; Dose-Response Relationship, Drug; Female; Grooming; Male; Motor Activity; Selegiline; Sex Characteristics; Stereotyped Behavior; Urination; Vocalization, Animal | 1992 |
(-)deprenyl and (-)parafluorodeprenyl-treatment prevents age-related pigment changes in the substantia nigra. A TV-image analysis of neuromelanin.
Topics: Aging; Animals; Male; Melanins; Neurons; Pigmentation; Rats; Selegiline; Substantia Nigra | 1992 |
Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage.
Topics: Aging; Animals; Clorgyline; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nervous System Diseases; Neurons; Selegiline | 1991 |
Quantitative localization of human brain monoamine oxidase B by large section autoradiography using L-[3H]deprenyl.
Topics: Adult; Aged; Aging; Autoradiography; Brain; Caudate Nucleus; Female; Humans; Male; Monoamine Oxidase; Selegiline; Tomography, Emission-Computed | 1991 |
The effect of long-term treatment with deprenyl on basal and L-dopa evoked dopamine release in vitro from the corpus striatum of aged rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amphetamine; Animals; Corpus Striatum; Dopamine; In Vitro Techniques; Levodopa; Male; Rats; Selegiline | 1991 |
Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged rats.
Topics: Aggression; Aging; Animals; Cognition; Dose-Response Relationship, Drug; Habituation, Psychophysiologic; Male; Memory; Monoamine Oxidase Inhibitors; Rats; Rats, Inbred Strains; Selegiline; Space Perception; Swimming | 1991 |
Maintenance on L-deprenyl prolongs life in aged male rats.
Topics: Aging; Animals; Blood; Body Weight; Longevity; Male; Phenethylamines; Rats; Rats, Inbred F344; Selegiline | 1990 |
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Phenethylamines; Selegiline | 1987 |
Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl.
Topics: Aging; Animals; Corpus Striatum; Dopamine; Female; Longevity; Male; Ovariectomy; Phenethylamines; Rats; Rats, Inbred Strains; Reference Values; Selegiline; Sexual Behavior, Animal | 1989 |
The pharmacology of (-)deprenyl.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholine; Aging; Animals; Catecholamines; Corpus Striatum; Dopamine; Humans; Hydroxydopamines; In Vitro Techniques; Monoamine Oxidase; Oxidopamine; Phenethylamines; Pyridines; Selegiline | 1986 |
Enzyme histochemistry of monoamine oxidase in the heart of aged rats.
Topics: Aging; Animals; Clorgyline; Heart; Histocytochemistry; Male; Monoamine Oxidase; Myocardium; Rats; Rats, Inbred Strains; Selegiline | 1987 |
Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat.
Topics: Aging; Animals; Benzylamines; Blood-Brain Barrier; Brain; Cerebral Cortex; Clorgyline; Microcirculation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Rats; Rats, Inbred Strains; Selegiline; Substrate Specificity; Tryptamines | 1987 |
Extension of life span of rats by long-term (-)deprenyl treatment.
Topics: Aging; Animals; Life Expectancy; Male; Nerve Degeneration; Phenethylamines; Rats; Selegiline; Time Factors | 1988 |
The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenyl.
Topics: Aging; Animals; Corpus Striatum; Dopamine; Female; Life Expectancy; Male; Phenethylamines; Rats; Selegiline; Sexual Behavior, Animal | 1988 |